Financial Counselors Inc. Lowers Position in Colgate-Palmolive (CL)

Share on StockTwits

Financial Counselors Inc. lessened its stake in Colgate-Palmolive (NYSE:CL) by 6.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 20,588 shares of the company’s stock after selling 1,390 shares during the quarter. Financial Counselors Inc.’s holdings in Colgate-Palmolive were worth $1,225,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of CL. Timber Creek Capital Management LLC raised its holdings in Colgate-Palmolive by 247.1% during the 4th quarter. Timber Creek Capital Management LLC now owns 472 shares of the company’s stock valued at $28,000 after acquiring an additional 336 shares during the period. BerganKDV Wealth Management LLC bought a new stake in Colgate-Palmolive during the 4th quarter valued at $47,000. Farmers & Merchants Trust Co of Chambersburg PA raised its holdings in Colgate-Palmolive by 46.2% during the 4th quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 950 shares of the company’s stock valued at $57,000 after acquiring an additional 300 shares during the period. Moody National Bank Trust Division bought a new stake in Colgate-Palmolive during the 4th quarter valued at $94,000. Finally, Price Capital Management Inc. purchased a new position in shares of Colgate-Palmolive during the 3rd quarter valued at $121,000. 75.21% of the stock is currently owned by institutional investors and hedge funds.

In related news, Director John T. Cahill sold 5,780 shares of the company’s stock in a transaction on Thursday, January 31st. The shares were sold at an average price of $64.46, for a total value of $372,578.80. Following the completion of the transaction, the director now directly owns 27,820 shares in the company, valued at $1,793,277.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.02% of the stock is currently owned by insiders.

A number of research analysts have recently commented on CL shares. Goldman Sachs Group upgraded shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating in a research report on Tuesday, January 8th. Zacks Investment Research lowered shares of Colgate-Palmolive from a “hold” rating to a “strong sell” rating in a research report on Wednesday, January 30th. Jefferies Financial Group restated a “hold” rating and set a $61.00 price target on shares of Colgate-Palmolive in a research report on Friday, February 1st. Morgan Stanley reduced their price target on shares of Colgate-Palmolive from $65.00 to $60.00 and set a “hold” rating for the company in a research report on Tuesday, October 30th. Finally, JPMorgan Chase & Co. lowered shares of Colgate-Palmolive from a “neutral” rating to an “underweight” rating and reduced their price target for the company from $61.00 to $54.00 in a research report on Monday, October 29th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have issued a buy rating to the company. Colgate-Palmolive has a consensus rating of “Hold” and an average target price of $65.00.

Shares of NYSE:CL opened at $65.69 on Monday. Colgate-Palmolive has a 52-week low of $57.41 and a 52-week high of $72.61. The firm has a market capitalization of $56.97 billion, a P/E ratio of 22.12, a P/E/G ratio of 4.24 and a beta of 0.78.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 25th. The company reported $0.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.73 by $0.01. Colgate-Palmolive had a net margin of 15.44% and a return on equity of 25,268.29%. The company had revenue of $3.81 billion during the quarter, compared to analyst estimates of $3.78 billion. During the same period in the previous year, the business earned $0.75 earnings per share. The firm’s quarterly revenue was down 2.1% compared to the same quarter last year. As a group, analysts predict that Colgate-Palmolive will post 2.83 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, February 15th. Investors of record on Wednesday, January 23rd will be given a $0.42 dividend. The ex-dividend date of this dividend is Tuesday, January 22nd. This represents a $1.68 annualized dividend and a yield of 2.56%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.57%.

TRADEMARK VIOLATION WARNING: “Financial Counselors Inc. Lowers Position in Colgate-Palmolive (CL)” was first published by Highlight Press and is the sole property of of Highlight Press. If you are viewing this story on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright legislation. The original version of this story can be accessed at https://highlightpress.com/2019/02/11/financial-counselors-inc-lowers-position-in-colgate-palmolive-cl.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

Read More: What is a Market Correction?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply